Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice

被引:16
作者
Schoeberlein, A
Schatt, S
Troeger, C
Surbek, D
Holzgreve, W
Hahn, S
机构
[1] Univ Basel Hosp, Univ Womens Hosp, Lab Prenatal Med, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland
关键词
D O I
10.1089/scd.2004.13.677
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This study was undertaken to evaluate the kinetics of engraftment after in utero transplantation of murine fetal liver and human cord blood stem cells in the nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse model. NOD/SCID fetuses were injected with murine fetal liver or human cord blood CD34(+) cells at day 13.5 of gestation. Frequencies of donor cells were analyzed by flow cytometry up to 48 h post transplantation and 4-16 weeks postnatally. Hematopoietic multilineage reconstitution capacity was assessed. Both types of donor cells home rapidly. However, the frequency of human cord blood stem cells rapidly diminished while the murine fetal liver stem cells expanded over time, resulting in multilineage hematopoietic reconstitution. Differences in long-term reconstitution of allogeneic versus xenogeneic donor cells were ascribed to the inability of the human cells to self-renew and differentiate in the fetal mouse environment, demonstrating the limitations of this commonly used xenograph.
引用
收藏
页码:677 / 684
页数:8
相关论文
共 24 条
[1]   Sustained multilineage engraftment of allogeneic hematopoietic stent cells in NOD/SCID mice after in utero transplantation [J].
Archer, DR ;
Turner, CW ;
Yeager, AM ;
Fleming, WH .
BLOOD, 1997, 90 (08) :3222-3229
[2]   Hematopoietic stem cells engraft in mice with absolute efficiency [J].
Benveniste, P ;
Cantin, C ;
Hyam, D ;
Iscove, NN .
NATURE IMMUNOLOGY, 2003, 4 (07) :708-713
[3]   IN-UTERO TRANSFER OF ADULT BONE-MARROW CELLS INTO RECIPIENTS WITH SEVERE COMBINED IMMUNODEFICIENCY DISORDER YIELDS LYMPHOID PROGENY WITH T-CELL AND B-CELL FUNCTIONAL CAPABILITIES [J].
BLAZAR, BR ;
TAYLOR, PA ;
VALLERA, DA .
BLOOD, 1995, 86 (11) :4353-4366
[4]   In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers [J].
Flake, AW ;
Zanjani, ED .
BLOOD, 1999, 94 (07) :2179-2191
[5]   Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow [J].
Flake, AW ;
Roncarolo, MG ;
Puck, JM ;
AlmeidaPorada, G ;
Evans, MI ;
Johnson, MP ;
Abella, EM ;
Harrison, DD ;
Zanjani, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24) :1806-1810
[6]  
Hogan C J, 1997, Biol Blood Marrow Transplant, V3, P236
[7]   Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow [J].
Holyoake, TL ;
Nicolini, FE ;
Eaves, CJ .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (09) :1418-1427
[8]   Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy [J].
Larochelle, A ;
Vormoor, J ;
Hanenberg, H ;
Wang, JCY ;
Bhatia, M ;
Lapidot, T ;
Moritz, T ;
Murdoch, B ;
Xiang, LX ;
Kato, I ;
Williams, DA ;
Dick, JE .
NATURE MEDICINE, 1996, 2 (12) :1329-1337
[9]   Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: Current status and future application [J].
Lu, L ;
Shen, RN ;
Broxmeyer, HE .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 22 (02) :61-78
[10]  
PALLAVICINI MG, 1992, TRANSPLANT P, V24, P542